U.S. flag

An official website of the United States government

NM_000545.8(HNF1A):c.502C>T (p.Arg168Cys) AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jul 21, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003002133.2

Allele description [Variation Report for NM_000545.8(HNF1A):c.502C>T (p.Arg168Cys)]

NM_000545.8(HNF1A):c.502C>T (p.Arg168Cys)

Gene:
HNF1A:HNF1 homeobox A [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q24.31
Genomic location:
Preferred name:
NM_000545.8(HNF1A):c.502C>T (p.Arg168Cys)
HGVS:
  • NC_000012.12:g.120989008C>T
  • NG_011731.2:g.15263C>T
  • NM_000545.8:c.502C>TMANE SELECT
  • NM_001306179.2:c.502C>T
  • NM_001406915.1:c.502C>T
  • NP_000536.5:p.Arg168Cys
  • NP_000536.6:p.Arg168Cys
  • NP_001293108.2:p.Arg168Cys
  • NP_001393844.1:p.Arg168Cys
  • LRG_522t1:c.502C>T
  • LRG_522:g.15263C>T
  • LRG_522p1:p.Arg168Cys
  • NC_000012.11:g.121426811C>T
  • NM_000545.5:c.502C>T
Protein change:
R168C
Molecular consequence:
  • NM_000545.8:c.502C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001306179.2:c.502C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406915.1:c.502C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003295117Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jul 21, 2022)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias.

Dron JS, Wang J, McIntyre AD, Iacocca MA, Robinson JF, Ban MR, Cao H, Hegele RA.

BMC Med Genomics. 2020 Feb 10;13(1):23. doi: 10.1186/s12920-020-0669-2.

PubMed [citation]
PMID:
32041611
PMCID:
PMC7011550

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003295117.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 168 of the HNF1A protein (p.Arg168Cys). This variant is present in population databases (rs764434453, gnomAD 0.002%). This missense change has been observed in individual(s) with dyslipidemias (PMID: 32041611). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt HNF1A protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024